In this section we give you an overview of the latest news and updates regarding the development of DEBx Medical and our product DEBRICHEM. Follow us on LinkedIn for more up-to-date content!
TVM Capital Healthcare Announces Euro 10 Million Investment in DEBx Medical DEBx Medical is innovating the management of chronic wounds, improving the life of millions
We are excited to announce that our latest paper, “Combining an Acidic Compound and NPWT: Debridement and Granulation in Leg and Foot Ulcers”, has recently
A new peer-reviewed paper on our novel debriding agent DEBRICHEM® was published in the October edition of the Journal of Wound Care. The article is
At the end of this week, DEBx Medical will participate in the Commonwealth and 4th Global Wound Conference at the Sunway Pyramid Convention Center in
Today marks the 2nd annual International Stop Wound Infection Day. This day is about raising awareness of effective identification, prevention and management strategies for wound
Now that the summer holidays are coming to an end and everyone is getting back to work, the focus shifts to all upcoming events and
Peer-reviewed paper on cost-effectiveness of Debrichem published in Journal of Wound Care and presented by Prof. Julian F. Guest at EWMA conference. Topical debridement gel
We are delighted to be attending the joint EWMA & Journées Cicatrisations Conference on 23-25 May 2022 in Paris next week! During the conference, we
